Atlas Trials

Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma

Clinical trial NCT02513199 · COMPLETED

Trial details

NCT number
NCT02513199
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2014-11-01
Primary completion
2022-01-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.